Literature DB >> 23217309

The experimental study of Astragalus membranaceus on meridian tropsim: the distribution study of astragaloside IV in rat tissues.

Yan-Xu Chang1, Yu-Gang Sun, Jin Li, Qiu-Hong Zhang, Xin-Rong Guo, Bo-Li Zhang, Hua Jin, Xiu-Mei Gao.   

Abstract

According to Traditional Chinese Medicine (TCM) theories, TCM with different meridian tropism have different therapeutic effects. In view of the meridian tropism of Astragalus membranaceus (Huangqi), astragaloside IV, one of the effective phytochemicals of Huangqi, was appointed and observed its distribution in rat tissues following a single intravenous (i.v.) dose. A simple and accurate LC-ESI-MS/MS method was developed and validated for astragaloside IV quantification in heart, liver, spleen, lung and kidney using warfarin as an internal standard (IS). Chromatographic separation was performed on a Eclipse plus C18 (4.6mm×100mm, 1.8μm) when the flow rate was set at 0.300mLmin(-1) and ammonium acetate aqueous solution - acetonitrile was used as mobile phase. The intra- and inter-day precisions of the quality control samples were within 15% and accuracies were within 90.0-110%. The recoveries were more than 90.0% at high, medium and low concentrations, respectively. This method was successfully applied for distribution of astragaloside IV after intravenous (i.v.) dose of 4mgkg(-1) astragaloside IV in rats. Astragaloside IV concentration was highest in liver and kidney and remained much higher than that in other tissues over the experiment course. Lung, heart and spleen were also detected to contain astragaloside IV. The results clearly demonstrated that astragaloside IV was one of the material bases of the meridian tropism of Huangqi. Crown
Copyright © 2012. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23217309     DOI: 10.1016/j.jchromb.2012.10.024

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

1.  Occurrence of ochratoxin A in Astragalus propinquus root and its transfer to decoction.

Authors:  Jakub Toman; Vladimir Ostry; Yann Grosse; Tomas Roubal; Frantisek Malir
Journal:  Mycotoxin Res       Date:  2018-04-25       Impact factor: 3.833

2.  Astragaloside IV attenuates glycated albumin-induced epithelial-to-mesenchymal transition by inhibiting oxidative stress in renal proximal tubular cells.

Authors:  Weiwei Qi; Jianying Niu; Qiaojing Qin; Zhongdong Qiao; Yong Gu
Journal:  Cell Stress Chaperones       Date:  2013-05-30       Impact factor: 3.667

3.  Development and Validation of a Rapid and Simple UPLC-ESI-MS Method for Pharmacokinetics and Tissue Distribution of Astragaloside III in Rats.

Authors:  Xiao-Hua Liu; Long Guo; Ying-Lai Yang; Fang Hu; Xin-Yue Chen; Shi-Lan Feng
Journal:  J Chromatogr Sci       Date:  2016-02-29       Impact factor: 1.618

Review 4.  A systematic review of anticancer effects of radix astragali.

Authors:  Yeehong Jung; Uimin Jerng; Sookyung Lee
Journal:  Chin J Integr Med       Date:  2015-12-07       Impact factor: 1.978

5.  Systems Pharmacological Approach of Pulsatillae Radix on Treating Crohn's Disease.

Authors:  Su Yeon Suh; Won G An
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-01       Impact factor: 2.629

Review 6.  Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation.

Authors:  Ying Yang; Meng Hong; Wen-Wen Lian; Zhi Chen
Journal:  World J Clin Cases       Date:  2022-10-06       Impact factor: 1.534

7.  Astragaloside IV Suppresses Hepatic Proliferation in Regenerating Rat Liver after 70% Partial Hepatectomy via Down-Regulation of Cell Cycle Pathway and DNA Replication.

Authors:  Gyeong-Seok Lee; Hee-Yeon Jeong; Hyeon-Gung Yang; Young-Ran Seo; Eui-Gil Jung; Yong-Seok Lee; Kung-Woo Nam; Wan-Jong Kim
Journal:  Molecules       Date:  2021-05-13       Impact factor: 4.411

8.  Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.

Authors:  Ya-Ning Wang; Shi-Li Zhao; Yan-Yan Su; Jun-Xia Feng; Shuai Wang; Xiao-Ming Liao; Li-Na Wang; Jing-Chun Li; Ping Meng; Hong-Yan Li; Yun-Fang Zhang
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

9.  Identification of the Perturbed Metabolic Pathways Associating With Renal Fibrosis and Evaluating Metabolome Changes of Pretreatment With Astragalus polysaccharide Through Liquid Chromatography Quadrupole Time-Of-Flight Mass Spectrometry.

Authors:  Lei Ren; Xiao-Ying Guo; Fei Gao; Mei-Li Jin; Xiang-Nan Song
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.